Farmacia
Facultad
University of Bologna
Bolonia, ItaliaPublicaciones en colaboración con investigadores/as de University of Bologna (43)
2023
-
A research agenda for nonvascular photoautotrophs under climate change
New Phytologist, Vol. 237, Núm. 5, pp. 1495-1504
-
Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models
European Journal of Medicinal Chemistry, Vol. 245
-
Ellenberg-type indicator values for European vascular plant species
Journal of Vegetation Science, Vol. 34, Núm. 1
-
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease
Bioorganic and Medicinal Chemistry, Vol. 91
-
The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis
Phytomedicine, Vol. 108
2022
-
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
ACS Chemical Neuroscience, Vol. 13, Núm. 15, pp. 2252-2260
2021
-
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease
ACS Chemical Neuroscience, Vol. 12, Núm. 8, pp. 1328-1342
-
Benchmarking plant diversity of Palaearctic grasslands and other open habitats
Journal of Vegetation Science, Vol. 32, Núm. 4
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
-
Post-glacial determinants of regional species pools in alpine grasslands
Global Ecology and Biogeography, Vol. 30, Núm. 5, pp. 1101-1115
2020
-
Triterpenoids isolated from Jatropha macrantha (Müll. Arg.) inhibit the NF-κB and HIF-1α pathways in tumour cells
Natural Product Research, pp. 1-5
2019
-
Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy
Molecules, Vol. 24, Núm. 8
-
Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold
European Journal of Medicinal Chemistry, Vol. 171, pp. 38-53
-
Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines
Chemical Record, Vol. 19, Núm. 5, pp. 927-937
2018
-
GrassPlot - A database of multi-scale plant diversity in Palaearctic grasslands
Phytocoenologia, Vol. 48, Núm. 3, pp. 331-347
-
Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 155, pp. 839-846
2017
-
5-Methyl-: N -(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5 H -indolo[2,3- b] quinolin-11-amine: A highly potent human cholinesterase inhibitor
MedChemComm, Vol. 8, Núm. 6, pp. 1307-1317
-
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity
European Journal of Medicinal Chemistry, Vol. 141, pp. 138-148
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734